Therapies Offered at Residential Addiction Treatment Programs in the United States
This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofi...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2020-08, Vol.324 (8), p.804-806 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 806 |
|---|---|
| container_issue | 8 |
| container_start_page | 804 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 324 |
| creator | Beetham, Tamara Saloner, Brendan Gaye, Marema Wakeman, Sarah E Frank, Richard G Barnett, Michael L |
| description | This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status. |
| doi_str_mv | 10.1001/jama.2020.8969 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7448823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2769709</ama_id><sourcerecordid>2447302236</sourcerecordid><originalsourceid>FETCH-LOGICAL-a437t-cc56385ebeeaa4436d90a0c5364a1f8890366f58161b7e29b36d31690c7258083</originalsourceid><addsrcrecordid>eNpVkUtLJDEUhcMwMraP7SxmIQHX1d48Ko_NgMjoCIKD067D7aqUnaarqk3SA_57U7TKmE0g9zvnHnII-c5gzgDYxRp7nHPgMDdW2S9kxmphKlFb85XMAKyptDTykByltIZymNDfyKHgRkJt9Iw8LFY-4jb4RO-7zkffUsz0wafQ-iEH3NDLtg1NDuNAF9Fj7ssz_RPHp4h9omGgeeXp4xByUf7NmH06IQcdbpI_fbuPyeP1r8XV7-ru_ub26vKuQil0rpqmVsLUfuk9opRCtRYQmlooiawzxoJQqqsNU2ypPbfLQgimLDSa1waMOCY_977b3bL3bVOCRdy4bQw9xhc3YnCfJ0NYuafxn9NSGsNFMTh_M4jj886n7NbjLg4ls-NSagGcC1Wo-Z5q4phS9N3HBgZu6sBNHbipAzd1UARn_-f6wN8_vQA_9sCke59yrawGK14BLnGLKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2447302236</pqid></control><display><type>article</type><title>Therapies Offered at Residential Addiction Treatment Programs in the United States</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Beetham, Tamara ; Saloner, Brendan ; Gaye, Marema ; Wakeman, Sarah E ; Frank, Richard G ; Barnett, Michael L</creator><creatorcontrib>Beetham, Tamara ; Saloner, Brendan ; Gaye, Marema ; Wakeman, Sarah E ; Frank, Richard G ; Barnett, Michael L</creatorcontrib><description>This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2020.8969</identifier><identifier>PMID: 32840587</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Addictions ; Analgesics, Opioid - therapeutic use ; Behavior Therapy ; Behavior, Addictive - therapy ; Buprenorphine ; Drug abuse ; Drug addiction ; Health Care Surveys ; Humans ; Letter ; Letters ; Methadone ; Naloxone ; Narcotics ; Opioid-Related Disorders - drug therapy ; Opioid-Related Disorders - rehabilitation ; Opioid-Related Disorders - therapy ; Opioids ; Research Letter ; Residential Treatment ; Substance abuse treatment ; United States</subject><ispartof>JAMA : the journal of the American Medical Association, 2020-08, Vol.324 (8), p.804-806</ispartof><rights>Copyright American Medical Association Aug 25, 2020</rights><rights>Copyright 2020 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a437t-cc56385ebeeaa4436d90a0c5364a1f8890366f58161b7e29b36d31690c7258083</citedby><cites>FETCH-LOGICAL-a437t-cc56385ebeeaa4436d90a0c5364a1f8890366f58161b7e29b36d31690c7258083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2020.8969$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.8969$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,780,784,885,3338,27922,27923,76259,76262</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32840587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beetham, Tamara</creatorcontrib><creatorcontrib>Saloner, Brendan</creatorcontrib><creatorcontrib>Gaye, Marema</creatorcontrib><creatorcontrib>Wakeman, Sarah E</creatorcontrib><creatorcontrib>Frank, Richard G</creatorcontrib><creatorcontrib>Barnett, Michael L</creatorcontrib><title>Therapies Offered at Residential Addiction Treatment Programs in the United States</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.</description><subject>Addictions</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Behavior Therapy</subject><subject>Behavior, Addictive - therapy</subject><subject>Buprenorphine</subject><subject>Drug abuse</subject><subject>Drug addiction</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Letter</subject><subject>Letters</subject><subject>Methadone</subject><subject>Naloxone</subject><subject>Narcotics</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Opioid-Related Disorders - rehabilitation</subject><subject>Opioid-Related Disorders - therapy</subject><subject>Opioids</subject><subject>Research Letter</subject><subject>Residential Treatment</subject><subject>Substance abuse treatment</subject><subject>United States</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUtLJDEUhcMwMraP7SxmIQHX1d48Ko_NgMjoCIKD067D7aqUnaarqk3SA_57U7TKmE0g9zvnHnII-c5gzgDYxRp7nHPgMDdW2S9kxmphKlFb85XMAKyptDTykByltIZymNDfyKHgRkJt9Iw8LFY-4jb4RO-7zkffUsz0wafQ-iEH3NDLtg1NDuNAF9Fj7ssz_RPHp4h9omGgeeXp4xByUf7NmH06IQcdbpI_fbuPyeP1r8XV7-ru_ub26vKuQil0rpqmVsLUfuk9opRCtRYQmlooiawzxoJQqqsNU2ypPbfLQgimLDSa1waMOCY_977b3bL3bVOCRdy4bQw9xhc3YnCfJ0NYuafxn9NSGsNFMTh_M4jj886n7NbjLg4ls-NSagGcC1Wo-Z5q4phS9N3HBgZu6sBNHbipAzd1UARn_-f6wN8_vQA_9sCke59yrawGK14BLnGLKg</recordid><startdate>20200825</startdate><enddate>20200825</enddate><creator>Beetham, Tamara</creator><creator>Saloner, Brendan</creator><creator>Gaye, Marema</creator><creator>Wakeman, Sarah E</creator><creator>Frank, Richard G</creator><creator>Barnett, Michael L</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20200825</creationdate><title>Therapies Offered at Residential Addiction Treatment Programs in the United States</title><author>Beetham, Tamara ; Saloner, Brendan ; Gaye, Marema ; Wakeman, Sarah E ; Frank, Richard G ; Barnett, Michael L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a437t-cc56385ebeeaa4436d90a0c5364a1f8890366f58161b7e29b36d31690c7258083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Addictions</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Behavior Therapy</topic><topic>Behavior, Addictive - therapy</topic><topic>Buprenorphine</topic><topic>Drug abuse</topic><topic>Drug addiction</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Letter</topic><topic>Letters</topic><topic>Methadone</topic><topic>Naloxone</topic><topic>Narcotics</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Opioid-Related Disorders - rehabilitation</topic><topic>Opioid-Related Disorders - therapy</topic><topic>Opioids</topic><topic>Research Letter</topic><topic>Residential Treatment</topic><topic>Substance abuse treatment</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beetham, Tamara</creatorcontrib><creatorcontrib>Saloner, Brendan</creatorcontrib><creatorcontrib>Gaye, Marema</creatorcontrib><creatorcontrib>Wakeman, Sarah E</creatorcontrib><creatorcontrib>Frank, Richard G</creatorcontrib><creatorcontrib>Barnett, Michael L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beetham, Tamara</au><au>Saloner, Brendan</au><au>Gaye, Marema</au><au>Wakeman, Sarah E</au><au>Frank, Richard G</au><au>Barnett, Michael L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapies Offered at Residential Addiction Treatment Programs in the United States</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2020-08-25</date><risdate>2020</risdate><volume>324</volume><issue>8</issue><spage>804</spage><epage>806</epage><pages>804-806</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><abstract>This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>32840587</pmid><doi>10.1001/jama.2020.8969</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2020-08, Vol.324 (8), p.804-806 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7448823 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Addictions Analgesics, Opioid - therapeutic use Behavior Therapy Behavior, Addictive - therapy Buprenorphine Drug abuse Drug addiction Health Care Surveys Humans Letter Letters Methadone Naloxone Narcotics Opioid-Related Disorders - drug therapy Opioid-Related Disorders - rehabilitation Opioid-Related Disorders - therapy Opioids Research Letter Residential Treatment Substance abuse treatment United States |
| title | Therapies Offered at Residential Addiction Treatment Programs in the United States |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A57%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapies%20Offered%20at%20Residential%20Addiction%20Treatment%20Programs%20in%20the%20United%20States&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Beetham,%20Tamara&rft.date=2020-08-25&rft.volume=324&rft.issue=8&rft.spage=804&rft.epage=806&rft.pages=804-806&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2020.8969&rft_dat=%3Cproquest_pubme%3E2447302236%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2447302236&rft_id=info:pmid/32840587&rft_ama_id=2769709&rfr_iscdi=true |